Metabolic targeting of HIF1 potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
More From BioPortfolio on "Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer"